DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on April 12, 2006; DOI: 10.1124/dmd.105.008250


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.008250v1
34/7/1152    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard B. van Breemen
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, J.
Right arrow Articles by van Breemen, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, J.
Right arrow Articles by van Breemen, R. B.


Received for publication November 11, 2005.
Revised April 4, 2006.
Accepted for publication April 5, 2006.

Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.)

Jian Guo 1, Dejan Nikolic 1, Lucas R. Chadwick 1, Guido F. Pauli 1, Richard B. van Breemen 2*

1 University of Illinois College of Pharmacy 2 University of Ilinois College of Pharmacy

* Address correspondence to: E-mail: breemen{at}uic.edu

Abstract

The female flowers of hops (Humulus lupulus L.) are used in the brewing of beer and are under investigation for use in dietary supplements for the management of menopausal symptoms in women. Hop extracts contain the weakly estrogenic compound isoxanthohumol, pro-estrogenic xanthohumol, and the potent estrogen 8-prenylnaringenin. Since isoxanthohumol can be metabolized in the human liver to form 8-prenylnaringenin, the specific cytochrome P450 enzymes responsible for this O-demethylation reaction were identified. In addition, the enzymes that convert isoxanthohumol and 8-prenylnarigenin to their most abundant metabolites were identified, since these metabolic pathways might also affect the estrogenicity of hop preparations. Specifically, the CYP450 enzymes that catalyze the oxidation of the prenyl side chains of isoxanthohumol and 8-prenylnarigenin into trans or cis alcohols were investigated. Human liver microsomes and monoclonal antibodies that inhibit specific CYP450 enzymes were used in combination with liquid chromatography-mass spectrometry to identify the enzymes responsible for these transformations. CYP2C19 was found to catalyze the formation of both cis and trans alcohols of the prenyl side chain of 8 prenylnarigenin with Km values of 14.8 ± 3.2 µM and 16.6 ± 4.6 µM, respectively. CYP2C8 converted 8-prenylnarigenin regioselectively to the trans alcohol of the prenyl group with a Km of 3.7 ± 0.9 µM. Finally, CYP1A2 was found to catalyze the O-demethylation of isoxanthohumol to generate 8-prenlynarigenin, with a Km value of 17.8 ± 3.7 µM. These results suggest that the estrogenicity of hop constituents in vivo will depend in part upon metabolic conversion that might show individual variation.


Key words: cytochrome P450 isoforms, human CYP enzymes, liver microsomes, mass spectrometry, metabolite kinetics


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
N. R Farnsworth, E. C Krause, J. L Bolton, G. F Pauli, R. B van Breemen, and J. G Graham
The University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research for Women's Health: from plant to clinical use
Am. J. Clinical Nutrition, February 1, 2008; 87(2): 504S - 508S.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Guo, D. Liu, D. Nikolic, D. Zhu, J. M. Pezzuto, and R. B. van Breemen
In Vitro Metabolism of Isoliquiritigenin by Human Liver Microsomes
Drug Metab. Dispos., February 1, 2008; 36(2): 461 - 468.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.